Skip to main content
. 2015 Jul 28;10(7):e0133964. doi: 10.1371/journal.pone.0133964

Fig 2. Association of RANKL and OPG genotypes with their serum levels and RANKL/OPG ratio.

Fig 2

A, B. Soluble RANKL levels and the ratio of RANKL/OPG in serum samples of breast cancer patients with AI-related MS-AEs with either the CC genotype or GG genotype of the RANKL promoter SNP rs7984870 (CC = 76 vs. GG = 32). C, D. Soluble OPG levels and the ratio of RANKL/OPG in serum samples of breast cancer patients with AI-related MS-AEs with either the CC genotype or GG genotype of the OPG SNP rs2073618 (CC = 46 vs. GG = 59). *p < 0.05.